Economic Evaluetion of Fulvestrant 500 MG (F500) Versus Original Nonsteroidal Aromatase Inhibitors in Patient with Advanced Breast Canser in Russia (2 LINE THERAPY)
Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.2291
https://www.valueinhealthjournal.com/article/S1098-3015(14)04221-1/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1746
First Page :
A637
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04221-1&doi=10.1016/j.jval.2014.08.2291